{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:13:59Z","timestamp":1785039239185,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jphs.2021.12.003","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T02:28:25Z","timestamp":1639448905000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of fatty acid-binding proteins and dopamine receptors on \u03b1-synucleinopathy"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-7847","authenticated-orcid":false,"given":"Ichiro","family":"Kawahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00441-017-2730-9","article-title":"In\u00a0vivo models of alpha-synuclein transmission and propagation","volume":"373","author":"Recasens","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mds.27556","article-title":"Gut-brain axis and the spread of alpha-synuclein pathology: vagal highway or dead end?","volume":"34","author":"Breen","year":"2019","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson's disease: a systematic review and meta-analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"Suppl 1","key":"10.1016\/j.jphs.2021.12.003_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J\u00a0Neurochem"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00685366","article-title":"Presenile dementia with alzheimer-, pick- and lewy-body changes","volume":"36","author":"Kosaka","year":"1976","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00690978","article-title":"Lewy bodies in cerebral cortex, report of three cases","volume":"42","author":"Kosaka","year":"1978","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"Dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol"},{"issue":"4\u20135","key":"10.1016\/j.jphs.2021.12.003_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"Kovari","year":"2009","journal-title":"Brain Res Bull"},{"issue":"11","key":"10.1016\/j.jphs.2021.12.003_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","article-title":"Incidence of dementia with Lewy bodies and Parkinson disease dementia","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.jphs.2021.12.003_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","article-title":"Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update","volume":"119","author":"Jellinger","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"41","key":"10.1016\/j.jphs.2021.12.003_bib12","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.0406283101","article-title":"Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions","volume":"101","author":"Chandra","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5999","key":"10.1016\/j.jphs.2021.12.003_bib13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in\u00a0vivo and in\u00a0vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"issue":"Pt 15","key":"10.1016\/j.jphs.2021.12.003_bib14","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J\u00a0Cell Sci"},{"issue":"23","key":"10.1016\/j.jphs.2021.12.003_bib15","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","article-title":"Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in\u00a0vitro and in\u00a0vivo","volume":"285","author":"Lou","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.jphs.2021.12.003_bib16","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A\u00a0role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","article-title":"Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter","volume":"8","author":"Matsuoka","year":"2001","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice","volume":"77","author":"Rathke-Hartlieb","year":"2001","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","article-title":"Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice","volume":"175","author":"Richfield","year":"2002","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci Lett"},{"issue":"5688","key":"10.1016\/j.jphs.2021.12.003_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"issue":"35","key":"10.1016\/j.jphs.2021.12.003_bib22","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib23","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/acn3.729","article-title":"Plasma alpha-synuclein detected by single molecule array is increased in PD","volume":"6","author":"Ng","year":"2019","journal-title":"Annal Clin Translational Neurol"},{"issue":"6","key":"10.1016\/j.jphs.2021.12.003_bib25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2008.02.014","article-title":"Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice","volume":"435","author":"Alerte","year":"2008","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.jphs.2021.12.003_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113779","article-title":"Degradation of tyrosine hydroxylase by the ubiquitin-proteasome system in the pathogenesis of Parkinson's disease and dopa-responsive dystonia","volume":"21","author":"Kawahata","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1471-4159.2002.01172.x","article-title":"Regulation of tyrosine hydroxylase by stress-activated protein kinases","volume":"83","author":"Toska","year":"2002","journal-title":"J\u00a0Neurochem"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2006.11.013","article-title":"Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism","volume":"26","author":"Collier","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"22","key":"10.1016\/j.jphs.2021.12.003_bib32","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1093\/nar\/gkm1059","article-title":"DNA replication stress, genome instability and aging","volume":"35","author":"Burhans","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12312","article-title":"Parkinson's disease as a result of aging","volume":"14","author":"Rodriguez","year":"2015","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.jphs.2021.12.003_bib34","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.18632\/aging.101721","article-title":"Protein synthesis and quality control in aging","volume":"10","author":"Anisimova","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.jphs.2021.12.003_bib36","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat Neurosci"},{"issue":"19","key":"10.1016\/j.jphs.2021.12.003_bib39","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.15252\/embj.201591397","article-title":"alpha-synuclein assemblies sequester neuronal alpha3-Na+\/K+-ATPase and impair Na+ gradient","volume":"34","author":"Shrivastava","year":"2015","journal-title":"EMBO J"},{"issue":"344","key":"10.1016\/j.jphs.2021.12.003_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnins.2018.00344","article-title":"Import and export of misfolded alpha-synuclein","volume":"12","author":"Rodriguez","year":"2018","journal-title":"Front Neurosci"},{"issue":"6307","key":"10.1016\/j.jphs.2021.12.003_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.jphs.2021.12.003_bib42","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1096\/fj.201802051R","article-title":"Extracellular alpha-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis","volume":"33","author":"Kobayashi","year":"2019","journal-title":"Faseb J"},{"key":"10.1016\/j.jphs.2021.12.003_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2017.00172","article-title":"Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein","volume":"11","author":"Delenclos","year":"2017","journal-title":"Front Neurosci"},{"issue":"16","key":"10.1016\/j.jphs.2021.12.003_bib44","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1073\/pnas.171300598","article-title":"alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins","volume":"98","author":"Sharon","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"45","key":"10.1016\/j.jphs.2021.12.003_bib45","doi-asserted-by":"crossref","first-page":"41958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213663","article-title":"Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation","volume":"14","author":"van Diggelen","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib48","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41598-018-37584-6","article-title":"Early stages of aggregation of engineered alpha-synuclein monomers and oligomers in solution","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jmb.2004.09.078","article-title":"Direct observation of Abeta amyloid fibril growth and inhibition","volume":"344","author":"Ban","year":"2004","journal-title":"J\u00a0Mol Biol"},{"issue":"40","key":"10.1016\/j.jphs.2021.12.003_bib50","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.1206286109","article-title":"alpha-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5\/Plk2","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"4043","key":"10.1016\/j.jphs.2021.12.003_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.177.4043.56","article-title":"A\u00a0binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues","volume":"177","author":"Ockner","year":"1972","journal-title":"Science"},{"issue":"8\u20139","key":"10.1016\/j.jphs.2021.12.003_bib53","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1387\/ijdb.092976rl","article-title":"Fatty acid binding proteins in brain development and disease","volume":"54","author":"Liu","year":"2010","journal-title":"Int J Dev Biol"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum Genom"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0896-6273(94)90341-7","article-title":"Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS","volume":"12","author":"Feng","year":"1994","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib56","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1046\/j.1471-4159.1994.63051616.x","article-title":"Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain","volume":"63","author":"Bennett","year":"1994","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-3806(95)00099-Y","article-title":"Developmental role of fatty acid-binding proteins in mouse brain","volume":"89","author":"Sellner","year":"1995","journal-title":"Brain Res Dev Brain Res"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0891-0618(96)00192-5","article-title":"Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains","volume":"12","author":"Owada","year":"1996","journal-title":"J\u00a0Chem Neuroanat"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.85.4.329","article-title":"Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene","volume":"85","author":"Schaap","year":"1999","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.jphs.2021.12.003_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1096\/fasebj.13.8.805","article-title":"Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization","volume":"13","author":"Binas","year":"1999","journal-title":"Faseb J"},{"issue":"1\u20132","key":"10.1016\/j.jphs.2021.12.003_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01270583","article-title":"Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man","volume":"116","author":"Kleine","year":"1992","journal-title":"Mol Cell Biochem"},{"issue":"21","key":"10.1016\/j.jphs.2021.12.003_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215358","article-title":"Fatty acid-binding protein 3 is critical for alpha-synuclein uptake and MPP(+)-Induced mitochondrial dysfunction in cultured dopaminergic neurons","volume":"20","author":"Kawahata","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jphs.2021.12.003_bib63","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/ijms21062230","article-title":"Fatty acid binding protein 3 enhances the spreading and toxicity of alpha-synuclein in mouse brain","volume":"21","author":"Yabuki","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9010049","article-title":"Dopamine D2 long receptors are critical for caveolae-mediated alpha-synuclein uptake in cultured dopaminergic neurons","volume":"9","author":"Kawahata","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jphs.2021.12.003_bib65","doi-asserted-by":"crossref","first-page":"147383","DOI":"10.1016\/j.brainres.2021.147383","article-title":"Suppression of alpha-synuclein propagation after intrastriatal injection in FABP3 null mice","author":"Matsuo","year":"2021","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib66","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.49.5.1432","article-title":"MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia","volume":"49","author":"Perlmutter","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib67","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.neuroscience.2006.04.072","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine","volume":"141","author":"Tabbal","year":"2006","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.jphs.2021.12.003_bib68","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","article-title":"Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"43","author":"Lai","year":"2018","journal-title":"Neurochem Res"},{"issue":"s1","key":"10.1016\/j.jphs.2021.12.003_bib69","first-page":"S11","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0163-7258(94)90041-8","article-title":"Dopamine receptors: molecular biology, biochemistry and behavioural aspects","volume":"64","author":"Jackson","year":"1994","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(85)90041-3","article-title":"Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain","volume":"71","author":"De Keyser","year":"1985","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.jphs.2021.12.003_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems","volume":"36","author":"Brichta","year":"2013","journal-title":"Trends Neurosci"},{"issue":"10","key":"10.1016\/j.jphs.2021.12.003_bib73","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0006-3223(91)90120-B","article-title":"Bennett Award paper. Expression of the dopamine D2 receptor gene in brain","volume":"30","author":"Meador-Woodruff","year":"1991","journal-title":"Biol Psychiatr"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"issue":"13","key":"10.1016\/j.jphs.2021.12.003_bib75","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1989.tb08585.x","article-title":"The dopamine D2 receptor: two molecular forms generated by alternative splicing","volume":"8","author":"Dal Toso","year":"1989","journal-title":"EMBO J"},{"issue":"13","key":"10.1016\/j.jphs.2021.12.003_bib76","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1073\/pnas.95.13.7731","article-title":"Prominence of the dopamine D2 short isoform in dopaminergic pathways","volume":"95","author":"Khan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib77","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuropharm.2005.11.010","article-title":"Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function","volume":"50","author":"Jomphe","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1471-4159.2004.02476.x","article-title":"Different activation of NF-kappaB by stimulation of dopamine D2L and D2S receptors through calcineurin activation","volume":"90","author":"Takeuchi","year":"2004","journal-title":"J\u00a0Neurochem"},{"issue":"2\u20133","key":"10.1016\/j.jphs.2021.12.003_bib79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuropharm.2010.09.018","article-title":"Isoform-specific uncoupling of the D2 dopamine receptors subtypes","volume":"60","author":"Kendall","year":"2011","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.jphs.2021.12.003_bib80","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.mp.4001145","article-title":"Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice","volume":"7","author":"Xu","year":"2002","journal-title":"Mol Psychiatr"},{"issue":"7","key":"10.1016\/j.jphs.2021.12.003_bib81","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0730708100","article-title":"Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites","volume":"100","author":"Lindgren","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2004.07.043","article-title":"Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum","volume":"129","author":"Centonze","year":"2004","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.jphs.2021.12.003_bib83","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1471-4159.2004.02446.x","article-title":"Dopamine D2 receptor activates extracellular signal-regulated kinase through the specific region in the third cytoplasmic loop","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J\u00a0Neurochem"},{"issue":"4","key":"10.1016\/j.jphs.2021.12.003_bib84","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1471-4159.2003.01763.x","article-title":"Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells","volume":"85","author":"Takeuchi","year":"2003","journal-title":"J\u00a0Neurochem"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1620\/tjem.214.213","article-title":"Fatty acid binding protein: localization and functional significance in the brain","volume":"214","author":"Owada","year":"2008","journal-title":"Tohoku J Exp Med"},{"issue":"27","key":"10.1016\/j.jphs.2021.12.003_bib86","doi-asserted-by":"crossref","first-page":"18957","DOI":"10.1074\/jbc.M113.527341","article-title":"FABP3 protein promotes alpha-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity","volume":"289","author":"Shioda","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2021.12.003_bib87","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.jbc.2021.100663","article-title":"An alpha-synuclein decoy peptide prevents cytotoxic alpha-synuclein aggregation caused by fatty acid binding protein 3","author":"Fukui","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"49","key":"10.1016\/j.jphs.2021.12.003_bib88","doi-asserted-by":"crossref","first-page":"34272","DOI":"10.1074\/jbc.M109.049809","article-title":"Fibril fragmentation enhances amyloid cytotoxicity","volume":"284","author":"Xue","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbr.2008.09.007","article-title":"Emotional response in dopamine D2L receptor-deficient mice","volume":"195","author":"Hranilovic","year":"2008","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of alpha-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brainres.2006.09.079","article-title":"Alpha-synuclein enhances dopamine D2 receptor signaling","volume":"1124","author":"Kim","year":"2006","journal-title":"Brain Res"},{"issue":"18","key":"10.1016\/j.jphs.2021.12.003_bib92","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1074\/jbc.M112.443945","article-title":"Plasma membrane compartmentalization of D2 dopamine receptors","volume":"288","author":"Sharma","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib93","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1476-5381.2011.01787.x","article-title":"The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes","volume":"166","author":"Cho","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tcm.2005.04.001","article-title":"Caveolae, lipid rafts, and vascular disease","volume":"15","author":"Li","year":"2005","journal-title":"Trends Cardiovasc Med"},{"issue":"22","key":"10.1016\/j.jphs.2021.12.003_bib95","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s00018-010-0447-y","article-title":"Caveolin regulation of neuronal intracellular signaling","volume":"67","author":"Stern","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib96","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuint.2011.05.017","article-title":"Caveolin-1 interacts with alpha-synuclein and mediates toxic actions of cellular alpha-synuclein overexpression","volume":"59","author":"Madeira","year":"2011","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.141.1.85","article-title":"Dynamin-mediated internalization of caveolae","volume":"141","author":"Henley","year":"1998","journal-title":"J\u00a0Cell Biol"},{"issue":"6","key":"10.1016\/j.jphs.2021.12.003_bib98","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","article-title":"Dynasore, a cell-permeable inhibitor of dynamin","volume":"10","author":"Macia","year":"2006","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib99","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/glia.23920","article-title":"Extracellular clusterin limits the uptake of alpha-synuclein fibrils by murine and human astrocytes","volume":"69","author":"Filippini","year":"2021","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.jphs.2021.12.003_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184040","article-title":"Proteasome impairment by \u03b1-synuclein","volume":"12","author":"Zondler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2021.12.003_bib101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuropharm.2019.03.029","article-title":"Inhibition of MPTP-induced alpha-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice","volume":"150","author":"Matsuo","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jphs.2021.12.003_bib102","doi-asserted-by":"crossref","first-page":"172891","DOI":"10.1016\/j.pbb.2020.172891","article-title":"Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice","volume":"191","author":"Haga","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.jphs.2021.12.003_bib103","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.3390\/ijms22126185","article-title":"T-type Ca(2+) enhancer SAK3 activates CaMKII and proteasome activities in Lewy body dementia mice model","volume":"22","author":"Xu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jphs.2021.12.003_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2021.02.006","article-title":"T-type Ca(2+) channel enhancer SAK3 administration improves the BPSD-like behaviors in App(NL-G-F\/NL-G-F) knock-in mice","volume":"146","author":"Degawa","year":"2021","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jphs.2021.12.003_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-Beta peptides trigger aggregation of alpha-synuclein in\u00a0vitro","volume":"25","author":"Koppen","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jphs.2021.12.003_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120635","article-title":"Fatty acid binding protein 5 mediates cell death by psychosine exposure through mitochondrial macropores formation in oligodendrocytes","volume":"8","author":"Cheng","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jphs.2021.12.003_bib107","article-title":"Fatty acid-binding protein 7 triggers alpha-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress","volume":"Online ahead of print","author":"Cheng","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.jphs.2021.12.003_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050560","article-title":"Impact of fatty acid-binding proteins in alpha-synuclein-induced mitochondrial injury in synucleinopathy","volume":"9","author":"Cheng","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.jphs.2021.12.003_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020110","article-title":"Epidermal fatty acid-binding protein 5 (FABP5) involvement in alpha-synuclein-induced mitochondrial injury under oxidative stress","volume":"9","author":"Wang","year":"2021","journal-title":"Biomedicines"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:01:47Z","timestamp":1761163307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1347861321001183"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.12.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of fatty acid-binding proteins and dopamine receptors on \u03b1-synucleinopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}